• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
For: Briand S, Milpied B, Navas D, Thomare P, Stalder JF. 1% topical cidofovir used as last alternative to treat viral infections. J Eur Acad Dermatol Venereol 2008;22:249-50. [PMID: 18211429 DOI: 10.1111/j.1468-3083.2007.02304.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Number Cited by Other Article(s)
1
Padilla España L, Boz J, Fernández‐Morano T, Escudero‐Santos I, Arenas‐Villafranca J, Troya M. Recalcitrant warts and topical cidofovir: predictive factors of good response. J Eur Acad Dermatol Venereol 2015;30:1218-20. [DOI: 10.1111/jdv.13145] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
2
Castelo-Soccio L, Bernardin R, Stern J, Goldstein SA, Kovarik C. Successful treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir. ACTA ACUST UNITED AC 2010;146:124-6. [PMID: 20157021 DOI: 10.1001/archdermatol.2009.363] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA